drugset / Trial / NCT06350058
Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The research objective is to evaluate the safety and tolerability of the inactivated rotavirus vaccine and explore its preliminary immunogenicity.
Timeline
- Start
- 2021-08-03
- Primary completion
- 2023-11-30
- Completion
- 2024-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Inactivated Rotavirus Vaccine | Vaccine | 2.5 ug | — |
| Subject | Inactivated Rotavirus Vaccine | Vaccine | 5 ug | — |
Indications
No indication recorded.